Literature DB >> 11564010

Glicentin, an active enteroglucagon, has a significant trophic role on the small intestine but not on the colon in the rat.

M Sasaki1, A J Fitzgerald, N Mandir, K Sasaki, N A Wright, R A Goodlad.   

Abstract

BACKGROUND: Many experiments have indicated that the gut glucagons (enteroglucagons) are associated with cell proliferation in the small intestine. However, recent studies have failed to show trophic effects of glicentin (enteroglucagon) on the intestine. AIMS: To examine the effects of glicentin on intestinal proliferation in vivo in the rat.
METHODS: Rats were established on total parenteral nutrition for 6 days. Four experimental groups were given daily doses of 1, 4, 20 and 80 microg/rat of glicentin via the jugular vein. Rats fed by total parenteral nutrition and rats fed chow ad libitum were used as controls. Tissues taken from the duodenum, jejunum, ileum and colon were fixed in Carnoy's fluid and microdissected to determine the metaphase arrest scores and crypt fission ratios.
RESULTS: The mean metaphase arrest scores per crypt of the small intestine were significantly increased in the rats given 4, 20 and 80 microg of glicentin. These responses were dose-dependent, and were most prominent in the ileum. Crypt fission of the ileum was significantly decreased in the 20 and 80 microg glicentin groups. Glicentin had no effects on proliferation or fission in the colon.
CONCLUSIONS: Glicentin is trophic to the rat small intestine, but not the colon.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11564010     DOI: 10.1046/j.1365-2036.2001.01082.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  4 in total

1.  Endocrine differentiation of rat enterocytes in long-term three-dimensional co-culture with intestinal myofibroblasts.

Authors:  Tetsuji Yoshikawa; Shinshichi Hamada; Eigo Otsuji; Hiroyuki Tsujimoto; Akeo Hagiwara
Journal:  In Vitro Cell Dev Biol Anim       Date:  2011-12       Impact factor: 2.416

2.  Postprandial Dynamics of Proglucagon Cleavage Products and Their Relation to Metabolic Health.

Authors:  Robert Wagner; Sabine S Eckstein; Louise Fritsche; Katsiaryna Prystupa; Sebastian Hörber; Hans-Ulrich Häring; Andreas L Birkenfeld; Andreas Peter; Andreas Fritsche; Martin Heni
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-29       Impact factor: 6.055

3.  The effects of lectins on indomethacin-induced small intestinal ulceration.

Authors:  Takashi Yasuoka; Masaya Sasaki; Tetsuya Fukunaga; Tomoyuki Tsujikawa; Yoshihide Fujiyama; Ryouji Kushima; Robert A Goodlad
Journal:  Int J Exp Pathol       Date:  2003-10       Impact factor: 1.925

Review 4.  Insights on glicentin, a promising peptide of the proglucagon family.

Authors:  Juliette Raffort; Fabien Lareyre; Damien Massalou; Patrick Fénichel; Patricia Panaïa-Ferrari; Giulia Chinetti
Journal:  Biochem Med (Zagreb)       Date:  2017-06-15       Impact factor: 2.313

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.